$COCO

Vita Coco’s (NASDAQ:COCO) Q3 2026: strong sales, full-year sales guidance is optimistic

Vita Coco (COCO) reported Q3 2026 revenue of $243.8M, beating estimates by 6.1%. EPS was $0.58, a 27.3% beat, and adjusted EBITDA was $53.16M, a 35.3% beat. The company raised full-year revenue guidance to $815M and EBITDA guidance to $172.5M, both above analyst estimates. Operating and free cash flow margins improved year-over-year.

Original reporting
Published Oct 22, 2026, 11:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vita Coco’s (NASDAQ:COCO) Q3 2026: strong sales, full-year sales guidance is optimistic — source image
Decision brief

The 30-second read

$COCOBullishHigh
01

Why it matters

The earnings beat and guidance lift are likely to drive short-term buying pressure, especially in after-hours trading.

02

Market read

First-report earnings with material beat and guidance raise; high relevance for traders seeking immediate moves.

03

What to watch

Potential supply chain constraints or commodity price volatility could impact margins.

Relevance 7/10Novelty 8/10Timing: after-hours reaction

Background

Vita Coco (NASDAQ:COCO) released its Q3 2026 earnings, beating estimates and raising full-year guidance.

Company-level read

Ticker impact

$COCOBullishHigh confidence
Context

Vita Coco reported Q3 2026 revenue beat and raised full-year revenue guidance to $815M.

Expected impact

likely upward as market prices in the beat and raised outlook

Evidence & confidence

Strong top-line growth, 33.7% YoY, and guidance lift are fresh, material information.

Market effects

Positive signal for the beverage sector and consumer discretionary trends.

U.S. market may see modest rally in similar niche consumer brands.

Limited to investors tracking small-cap consumer stocks.

Counterpoint

Guidance may be overly optimistic; execution risk could temper upside.

Key entities

  • Vita Coco

    Coconut water producer listed on NASDAQ.

Related articles

$COCOMed

Piper Sandler raises Vita Coco stock price target on earnings beat

Piper Sandler raised its price target for The Vita Coco Co. (NASDAQ:COCO) to $88 from $83, citing strong Q3 2026 results. The company reported 26.1% revenue growth and raised its sales guidance. Piper Sandler also increased its 2026 and 2027 EBITDA estimates. Vita Coco plans pricing increases to offset costs. The stock is trading at a low P/E ratio relative to earnings growth, with a PEG ratio of 0.45. Evercore ISI reiterated its Outperform rating with a $80 price target.

$COCOMedAI 8/10

Evercore ISI reiterates Vita Coco stock rating on demand strength

Evercore ISI reiterated an Outperform rating and $80 price target for The Vita Coco Co. Inc (COCO) after its Q3 results. The company beat expectations with $244M in net sales and $0.58 EPS, but shares fell 5% due to margin concerns. COCO's market cap is $3.63B, with shares down from a 52-week high of $85.83. Management expects low 20s% growth in 2026, up from prior forecasts. Supply chain issues have caused inventory shortages, but the company expects improvements in Q4 2026.

$COCOHighAI 8/10

The Vita Coco Co Inc (COCO) (Q3 2026) Earnings Call Highlights: Net Sales Surge 34%

The Vita Coco Co Inc (COCO) reported Q3 2026 net sales up 34% YoY to $244M, driven by strong coconut water and private label growth. International sales surged 48%. Full-year guidance was raised, but supply chain issues and cost pressures weighed on margins. Management expects capacity constraints to persist into early 2027 and deferred pricing to impact margins until then.

$COCOMed

Vita Coco (COCO) Q3 2026 Earnings Call Transcript

Vita Coco (COCO) reported Q3 2026 net sales up 34%, with coconut water and private label growth of 15% and 152% respectively. U.S. retail dollar sales grew 28%, while European markets saw 66% growth. The company plans to launch new products and expand supply chain capacity. Inflationary pressures impacted gross margins, with pricing adjustments expected in 2027.